Headlines Covid-19 Specialties Trending Feeds Videos

CRISPR Therapeutics - – More than 20 patients have been dosed with CTX001™ across CLIMB-Thal-111 and CLIMB-SCD-121 to date; completion of enrollment in both trials is expected in...

CRISPR Therapeutics Announces the Appointment of Philippe Drouet as Chief Commercial Officer | CRISPR Therapeutics

posted 3 weeks


Mashup Score: 3

CRISPR Therapeutics - ZUG, Switzerland and CAMBRIDGE, Mass. , Feb. 01, 2021 (GLOBE NEWSWIRE) — CRISPR Therapeutics  (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based...